Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edwin P Alyea

Showing results (131-140 of 176) with videos related to

Pageof 18
Sort By:
The New England Journal of Medicine|December 2, 2011
Interleukin-2 and regulatory T cells in graft-versus-host diseaseJohn Koreth, Ken-ichi Matsuoka, Haesook T Kim, et al.
Blood|May 5, 2018
High <i>NPM1</i>-mutant allele burden at diagnosis predicts unfavorable outcomes in de novo AMLSanjay S Patel, Frank C Kuo, Christopher J Gibson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 13, 2011
National Cancer Institute's First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: summary and recommendations from the organizing committeeMichael R Bishop, Edwin P Alyea, Mitchell S Cairo, et al.
Transfusion|January 23, 2009
High-resolution HLA matching in double-umbilical-cord-blood reduced-intensity transplantation in adultsMeghan Delaney, Corey S Cutler, Richard L Haspel, et al.
Blood|February 3, 2017
PD-1 modulates regulatory T-cell homeostasis during low-dose interleukin-2 therapyTakeru Asano, Yusuke Meguri, Takanori Yoshioka, et al.
JCI Insight|November 5, 2016
Low-dose IL-2 selectively activates subsets of CD4<sup>+</sup> Tregs and NK cellsMasahiro Hirakawa, Tiago R Matos, Hongye Liu, et al.
British Journal of Haematology|January 6, 2016
The addition of sirolimus to the graft-versus-host disease prophylaxis regimen in reduced intensity allogeneic stem cell transplantation for lymphoma: a multicentre randomized trialPhilippe Armand, Haesook T Kim, Marie-Michele Sainvil, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 15, 2018
Effect of Antihuman T Lymphocyte Globulin on Immune Recovery after Myeloablative Allogeneic Stem Cell Transplantation with Matched Unrelated Donors: Analysis of Immune Reconstitution in a Double-Blind Randomized Controlled TrialMahasweta Gooptu, Haesook T Kim, Yi-Bin Chen, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 31, 2011
Immune reconstitution after double umbilical cord blood stem cell transplantation: comparison with unrelated peripheral blood stem cell transplantationCaron A Jacobson, Amin T Turki, Sean M McDonough, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 4, 2015
Phase II Study of Allogeneic Transplantation for Older Patients With Acute Myeloid Leukemia in First Complete Remission Using a Reduced-Intensity Conditioning Regimen: Results From Cancer and Leukemia Group B 100103 (Alliance for Clinical Trials in Oncology)/Blood and Marrow Transplant Clinical Trial Network 0502Steven M Devine, Kouros Owzar, William Blum, et al.
Pageof 18

Showing results (131-140 of 176) with videos related to

Sort By:
Pageof 18
The New England Journal of Medicine|December 2, 2011
Interleukin-2 and regulatory T cells in graft-versus-host diseaseJohn Koreth, Ken-ichi Matsuoka, Haesook T Kim, et al.
Blood|May 5, 2018
High <i>NPM1</i>-mutant allele burden at diagnosis predicts unfavorable outcomes in de novo AMLSanjay S Patel, Frank C Kuo, Christopher J Gibson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 13, 2011
National Cancer Institute's First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: summary and recommendations from the organizing committeeMichael R Bishop, Edwin P Alyea, Mitchell S Cairo, et al.
Transfusion|January 23, 2009
High-resolution HLA matching in double-umbilical-cord-blood reduced-intensity transplantation in adultsMeghan Delaney, Corey S Cutler, Richard L Haspel, et al.
Blood|February 3, 2017
PD-1 modulates regulatory T-cell homeostasis during low-dose interleukin-2 therapyTakeru Asano, Yusuke Meguri, Takanori Yoshioka, et al.
JCI Insight|November 5, 2016
Low-dose IL-2 selectively activates subsets of CD4<sup>+</sup> Tregs and NK cellsMasahiro Hirakawa, Tiago R Matos, Hongye Liu, et al.
British Journal of Haematology|January 6, 2016
The addition of sirolimus to the graft-versus-host disease prophylaxis regimen in reduced intensity allogeneic stem cell transplantation for lymphoma: a multicentre randomized trialPhilippe Armand, Haesook T Kim, Marie-Michele Sainvil, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 15, 2018
Effect of Antihuman T Lymphocyte Globulin on Immune Recovery after Myeloablative Allogeneic Stem Cell Transplantation with Matched Unrelated Donors: Analysis of Immune Reconstitution in a Double-Blind Randomized Controlled TrialMahasweta Gooptu, Haesook T Kim, Yi-Bin Chen, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 31, 2011
Immune reconstitution after double umbilical cord blood stem cell transplantation: comparison with unrelated peripheral blood stem cell transplantationCaron A Jacobson, Amin T Turki, Sean M McDonough, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 4, 2015
Phase II Study of Allogeneic Transplantation for Older Patients With Acute Myeloid Leukemia in First Complete Remission Using a Reduced-Intensity Conditioning Regimen: Results From Cancer and Leukemia Group B 100103 (Alliance for Clinical Trials in Oncology)/Blood and Marrow Transplant Clinical Trial Network 0502Steven M Devine, Kouros Owzar, William Blum, et al.
Pageof 18